BioLife Solutions Inc. (NASDAQ: BLFS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BIOLIFE SOLUTIONS INC.

BioLife Solutions Inc. (NASDAQ: BLFS)
Listen to this Section


$26.45
-0.6400 ( -2.36% ) 194.4K

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Market Data


Open $26.45
Previous Close $27.09
Volume 194.4K
Market Cap $1.33B
Day Range $26.14 - $27.51
52 Week Range $17.86 - $29.62
Shares Outstanding 48.86M
Change % -2.36%
Net Change ▼ -0.6400
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical Instruments & Supplies
IPO Year1989
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -21,511.00

Date Type Amount Purchased Purchaser
2023-12-04 Sale -394.00 Aebersold Sarah
2023-11-15 Sale -98.00 Berard Todd
2023-11-15 Sale -76.00 Aebersold Sarah
2023-11-15 Sale -114.00 Foster Karen A.
2023-10-10 Sale -362.00 Ellingson Rachel
2023-10-10 Sale -281.00 Wichterman Troy
2023-10-10 Sale -282.00 Rice Michael
2023-10-10 Sale -252.00 Foster Karen A.
2023-10-10 Sale -362.00 MOORE TIMOTHY L.
2023-10-10 Sale -422.00 GOSWAMI JOYDEEP

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 13, 2025
10-q Quarterly Reports 110 Nov 06, 2025
8-k 8K-related 17 Nov 06, 2025
4 Insider transactions 1 Oct 28, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 22, 2025
4 Insider transactions 1 Oct 20, 2025
4 Insider transactions 1 Oct 17, 2025
4 Insider transactions 1 Oct 14, 2025
4 Insider transactions 1 Oct 14, 2025

Latest News


× Before browsing our site, please accept our cookies policy